ライフサイエンスコーパス: X-linked inhibitor of apoptosis protein

1 d the antiapoptotic factors Bcl-xL and XIAP (X-linked Inhibitor of Apoptosis Protein).

2 IR3 (baculovirus IAP repeat) domain of XIAP (X-linked inhibitor of apoptosis protein).

3 aspase activation by proteasome activity and X-linked inhibitor of apoptosis protein.

4 promoter of PDA chemotherapy resistance, the X-linked inhibitor of apoptosis protein.

5 include inhibitors of apoptosis proteins and X-linked inhibitor of apoptosis protein.

6 radation, or anti-apoptotic factors, such as x-linked inhibitor of apoptosis protein.

7 tivation by facilitating association between X-linked inhibitor of apoptosis protein, an inhibitor of

8 cIAP-1, cIAP-2, Bcl-2, Bcl-xL, survivin, and X-linked inhibitor of apoptosis protein, and up-regulate

9 caspase) mimetics to their target, the XIAP (X-linked inhibitor of apoptosis) protein, and their bind

10 CrmA), a suppressor of caspase-8, but not by X-linked inhibitor of apoptosis protein-baculovirus IAP

11 (L), or deletion of Smac) with expression of X-linked inhibitor of apoptosis protein decreases the se

12 t with ucf-101 before reperfusion attenuated X-linked inhibitor of apoptosis protein degradation and

13 ation, apoptosis-inducing factor, as well as X-linked inhibitor of apoptosis protein degradation, but

14 IL-6 increases expression of the endogenous X-linked inhibitor of apoptosis protein expression by tr

15 Conversely, negating X-linked inhibitor of apoptosis protein expression or fu

16 findings that IL-6 translationally regulates X-linked inhibitor of apoptosis protein expression revea

17 sine kinase localization at the membrane and X-linked inhibitor of apoptosis protein expression, resp

18 ellular inhibitor of apoptosis protein-1 and X-linked inhibitor of apoptosis protein, Fas-induced apo

19 c-Myc, matrix metalloproteinase-9, survivin, X-linked inhibitor-of-apoptosis protein (IAP), IAP1, Bcl

20 combinant adenovirus was used to express the X-linked inhibitor of apoptosis protein in these cells.

21 XIAP (X-linked inhibitor of apoptosis protein) is involved in

22 rtantly, GM-CSF prevented GC-induced loss of X-linked inhibitor of apoptosis protein, late activation

23 1 (copper metabolism MURR1 domain) and XIAP (X-linked inhibitor of apoptosis protein) may also be req

24 is a mitochondrial protein that binds XIAP (X-linked inhibitor of apoptosis protein) upon entering t

25 osis (IAP) family members (cIAP1, cIAP2, and X-linked inhibitor of apoptosis protein), was overexpres

26 the antiapoptotic proteins bcl-2, mcl-1, and X-linked inhibitor of apoptosis protein which occurs as

27 pase-3 and significantly increased levels of X-linked inhibitor of apoptosis protein, which also corr

28 3/1524A), the inhibitory interaction between X-linked inhibitor of apoptosis protein (XIAP) and caspa

29 d found to bind to the antiapoptotic protein X-linked inhibitor of apoptosis protein (XIAP) and showe

30 X-linked inhibitor of apoptosis protein (XIAP) antagonis

31 gned to mimic the binding of Smac protein to X-linked inhibitor of apoptosis protein (XIAP) are being

32 Overexpression studies have identified X-linked inhibitor of apoptosis protein (XIAP) as a pote

33 We have identified endogenous X-linked inhibitor of apoptosis protein (XIAP) as the es

34 and AKT2, interacts with and phosphorylates X-linked inhibitor of apoptosis protein (XIAP) at residu

35 s may be due to the high-level expression of X-linked inhibitor of apoptosis protein (XIAP) by CLL ce

36 mk or by expressing the BIR1/BIR2 domains of X-linked inhibitor of apoptosis protein (XIAP) decreased

37 s involved down-regulation of active AKT and X-linked inhibitor of apoptosis protein (XIAP) expressio

38 al. report on the prognostic significance of X-linked inhibitor of apoptosis protein (XIAP) in melano

39 e prognostic and therapeutic significance of X-linked inhibitor of apoptosis protein (XIAP) in melano

40 Our previous studies reported that X-linked inhibitor of apoptosis protein (XIAP) interacte

41 X-linked inhibitor of apoptosis protein (XIAP) is a pote

42 bition of activated CASP7 (p19/p12-CASP7) by X-linked inhibitor of apoptosis protein (XIAP) is a pote

43 The X-linked inhibitor of apoptosis protein (XIAP) is a pote

44 The X-linked inhibitor of apoptosis protein (XIAP) is a pote

45 X-linked inhibitor of apoptosis protein (XIAP) is a pote

46 Human X-linked inhibitor of apoptosis protein (XIAP) is a pote

47 The X-linked inhibitor of apoptosis protein (XIAP) is a well

48 We show here that X-linked inhibitor of apoptosis protein (xIAP) is essent

49 Apaf-1 and X-linked inhibitor of apoptosis protein (Xiap) mRNA were

50 as well as cells overexpressing full-length X-linked inhibitor of apoptosis protein (XIAP) or the BI

51 lls stably overexpressing either full-length X-linked inhibitor of apoptosis protein (XIAP) or the BI

52 X-linked inhibitor of apoptosis protein (XIAP) overexpre

53 TNFalpha-dependent apoptosis induction, and X-linked inhibitor of apoptosis protein (XIAP) plays a c

54 ptibility to apoptosis and determines if the X-linked inhibitor of apoptosis protein (XIAP) regulates

55 monstrate that the E3 ubiquitin ligase named x-linked inhibitor of apoptosis protein (XIAP) restricts

56 along with negative regulation of NF-kappaB- X-linked inhibitor of apoptosis protein (XIAP) signaling

57 ytosol, which activate apoptosis and inhibit X-linked inhibitor of apoptosis protein (XIAP) suppressi

58 Unexpectedly, binding of X-linked inhibitor of apoptosis protein (XIAP) to the Re

59 Endogenous caspase inhibitor X-linked inhibitor of apoptosis protein (XIAP) underwent

60 The X-linked inhibitor of apoptosis protein (XIAP) uses its

61 om mitochondria and subsequent inhibition of X-linked inhibitor of apoptosis protein (XIAP) was requi

62 Epithelial expression of X-linked inhibitor of apoptosis protein (XIAP), activati

63 sely, biochemical interactions occur between x-linked inhibitor of apoptosis protein (XIAP), an E3 ub

64 B-cell leukemia/lymphoma-2 protein (Bcl-2), X-linked inhibitor of apoptosis protein (XIAP), and myel

65 intracellular SLAM-associated protein (SAP), X-linked inhibitor of apoptosis protein (XIAP), and perf

66 of apoptosis proteins, including c-IAP1 and X-linked inhibitor of apoptosis protein (XIAP), are obli

67 The protein levels of X-linked inhibitor of apoptosis protein (XIAP), Bcl-xL,

68 a number of antiapoptotic proteins including X-linked inhibitor of apoptosis protein (XIAP), c-IAP1,

69 ral NF-kappaB-dependent antiapoptotic genes: X-linked inhibitor of apoptosis protein (XIAP), cIAP1, c

70 revealed a strong decrease of expression of X-linked inhibitor of apoptosis protein (XIAP), compared

71 Overexpression of the apoptotic regulator, X-linked inhibitor of apoptosis protein (XIAP), has been

72 X-linked inhibitor of apoptosis protein (XIAP), the most

73 his study, we found that CSR1 interacts with X-linked Inhibitor of Apoptosis Protein (XIAP), using ye

74 s, antiapoptotic proteins, such as Mcl-1 and X-linked inhibitor of apoptosis protein (XIAP), were rap

75 e-2 (XLP-2) is associated with deficiency in X-linked inhibitor of apoptosis protein (XIAP), with poo

76 ow that resveratrol induced p53-independent, X-linked inhibitor of apoptosis protein (XIAP)-mediated

77 lines LoVo and HCT-116 Smac(-/-), similar to X-linked inhibitor of apoptosis protein (XIAP)-overexpre

78 induction as well as down-regulation of the X-linked inhibitor of apoptosis protein (XIAP).

79 l cord and forms a protein assembly with the X-linked inhibitor of apoptosis protein (XIAP).

80 mimetics targeting the antiapoptotic protein X-linked inhibitor of apoptosis protein (XIAP).

81 ) and characterized its interaction with the X-linked inhibitor of apoptosis protein (XIAP).

82 inhibitor of apoptosis protein 1 (cIAP1) and X-linked inhibitor of apoptosis protein (XIAP).

83 X-linked inhibitor-of-apoptosis protein (XIAP) interacts

84 spase-8 and caspase-3 activation and reduced X-linked inhibitor-of-apoptosis protein (XIAP) levels in

85 Compound 2 binds to X-linked inhibitors of apoptosis proteins (XIAP) with a